accounts receivable

Class action lawsuit filed against Ardent Health for allegedly inflating receivables. Stock plunged 34% after $43M revenue decrease revealed in Q3 2025.

Class action lawsuit filed against Ardent Health alleging $57.5M EBITDA overstatement and Q3 revenue misstatement due to accounting system failures and undisclosed industry cost pressures.

Ardent Health faces securities lawsuit over accounting practices; investors with $100K+ losses urged to seek counsel before March 9, 2026 deadline.

The Gross Law Firm filed a class action against Ardent Health ($ARDT) alleging misrepresentation of accounts receivable collection and insufficient insurance coverage. Investors may qualify as lead plaintiffs.

Ardent Health ($ARDT) faces securities fraud lawsuit over alleged false statements on receivables collection and inadequate insurance coverage. Investors urged to join before March 9, 2026.

Class action filed against Ardent Health alleging $57.5M EBITDA overstatement and revenue misstatement following accounting system implementation failure.

Ardent Health faces securities fraud lawsuit over alleged failure to disclose collections problems. Stock fell 33% after November revelation of $43M revenue cut and $57.5M EBITDA guidance reduction.

Class action lawsuit filed against Ardent Health for accounting irregularities. Stock tumbled 34% after $43M revenue decrease discovery. Lead plaintiff deadline: March 9, 2026.

Rosen Law Firm files securities class action against Ardent Health for alleged misrepresentations in accounts receivable and insurance reserves. March 9 deadline for lead plaintiff claims.

Schall Law Firm launches class action against $ARDT for alleged false statements on receivables and insurance practices. Investor deadline: March 9, 2026.

Class action lawsuit filed against Ardent Health for alleged $57.5M EBITDA overstatement and revenue misstatements tied to new accounting systems and sector headwinds.

Bleichmar Fonti & Auld files securities fraud class action against Ardent Health after 33% stock plunge following $43M revenue decline disclosure. Deadline March 9.

Law firm announces March 9, 2026 deadline for shareholders to seek lead plaintiff status in securities class actions against Ardent Health and Varonis Systems over alleged misstatements.

Ardent Health faces class action lawsuit for overstating Q3 2025 revenue and EBITDA guidance by $57.5 million due to inadequate accounting assessments and cost pressures.

Bill Holdings stock hits decade lows as it shifts to profitability focus. Most analysts recommend buying, seeing 25% upside potential despite 86% decline from 2021 peak.

Ardent Health faces class action lawsuit over inflated receivables and delayed loss recognition. Stock dropped 34% after $43M revenue restatement; investors have until March 9 to join.

Pomerantz LLP sues Ardent Health for securities fraud over November 2025 disclosures revealing $43M revenue decrease and $57.5M EBITDA cut, causing 33.81% stock decline. Shareholders can join by March 9.

Ardent Health investors must join securities class action by March 9, 2026, alleging company misrepresented financial reporting and insurance coverage practices.

Ardent Health shares plunged 33% after revealing a $43 million revenue adjustment due to overstated receivables. A securities fraud lawsuit was filed over misleading accounting disclosures.

Securities lawsuit filed against Ardent Health for alleged accounting misrepresentations. Lead plaintiff deadline set for March 9, 2026.